Skip to main content

Identifying Restriction Factors for Hemorrhagic Fever Viruses: Dengue and Junín

  • Protocol
  • First Online:
Hemorrhagic Fever Viruses

Abstract

Host restriction factors are cellular components that interfere with viral multiplication. They are up-regulated and expressed upon viral infection and in consequence their activity is specific. So far several important restriction factors have been described against diverse viruses. The cellular antiviral mechanisms defined include proteins with the ability to interfere with early steps of viral replication and others that have been shown to block viral morphogenesis. However, other strategies by which the antiviral action is exerted still remain elusive. An additional interesting matter is how viruses also developed ways to by-pass these host-specific obstacles. Thus, unusual cell localization or re-localization represents a frequent virus choice to evade the cellular surveillance. In the present chapter, we summarize methods to identify cell restriction factors, their antiviral activity, and possible subcellular locations where their activity can take place.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yan N, Chen ZJ (2012) Intrinsic antiviral immunity. Nat Immunol 13(3):214–222

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Bowick GC, Fennewald SM, Elsom BL, Aronson JF, Luxon BA, Gorenstein DG, Herzog NK (2006) Differential signaling networks induced by mild and lethal hemorrhagic fever virus infections. J Virol 80:10248–10252

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Müller S, Geffers R, Günther S (2007) Analysis of gene expression in Lassa virus-infected HuH-7 cells. J Gen Virol 88:1568–1575

    Article  PubMed  Google Scholar 

  4. Djavani M, Crasta OR, Zhang Y, Zapata JC, Sobral B, Lechner MG, Bryant J, Davis H, Salvato MS (2009) Gene expression in primate liver during viral hemorrhagic fever. Virol J 6(20):1–20

    Google Scholar 

  5. Panda D, Das A, Dinh PX, Subramaniam S, Nayak D, Barrows NJ, Pearson JL, Thompson J, Kelly DL, Ladunga I, Pattnaik AK (2011) RNAi screening reveals requirement for host cell secretory pathway in infection by diverse families of negative-strand RNA viruses. Proc Natl Acad Sci U S A 108(47):19036–19041

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Panda D, Cherry S (2015) A genome-wide RNAi screening method to discover novel genes involved in virus infection. Methods 91:75–81

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lavanya M, Cuevas CD, Thomas M, Cherry S, Ross SR (2013) SiRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target. Sci Transl Med 5(204):204ra131

    Article  PubMed  PubMed Central  Google Scholar 

  8. Perez-Caballero D, Zang T, Ebrahimi A, Mcnatt MW, Gregory DA, Johnson MC, Bieniasz PD (2009) Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139:499–511

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tartour K, Appourchaux R, Gaillard J, Nguyen XN, Durand S, Turpin J, Beaumont E, Roch E, Berger G, Mahieux R, Brand D, Roingeard P, Cimarelli A (2014) IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity. Retrovirology 11:103

    Article  PubMed  PubMed Central  Google Scholar 

  10. Hinson ER, Cresswell P (2009) The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix. Proc Natl Acad Sci U S A 106(48):20452–20457

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Helbig KJ, Carr JM, Calvert JK, Wati S, Clarke JN et al (2013) Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Negl Trop Dis 7:e2178

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Jiang X, Chen ZJ (2011) Viperin links lipid bodies to immune defense. Immunity 34(3):285–287. doi:10.1016/j.immuni.2011.03.012

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Saka HA, Valdivia R (2012) Emerging roles for lipid droplets in immunity and host-pathogen interactions. Annu Rev Cell Dev Biol 28:411–437. doi:10.1146/annurev-cellbio-092910-153958

    Article  CAS  PubMed  Google Scholar 

  14. Bieniasz PD (2003) Restriction factors: a defense against retroviral infection. Trends Microbiol 11(6):286–291

    Article  CAS  PubMed  Google Scholar 

  15. Harris RS, Hultquist JF, Evans DT (2012) The restriction factors of human immunodeficiency virus. J Biol Chem 287:40875–40883

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Simon V, Bloch N, Landau NR (2015) Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat Immunol 16(6):546–553

    Article  CAS  PubMed  Google Scholar 

  17. Wang X, Hinson ER, Cresswell P (2007) The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2:96–105

    Article  CAS  PubMed  Google Scholar 

  18. Seo JY, Yaneva R, Hinson ER, Cresswell P (2011) Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 332:1093–1097

    Article  CAS  PubMed  Google Scholar 

  19. Lazear HM, Diamond MS (2015) New insights into innate immune restriction of West Nile virus infection. Curr Opin Virol 11:1–6

    Article  CAS  PubMed  Google Scholar 

  20. Zhou LY, Zhang LL (2016) Host restriction factors for hepatitis C virus. World J Gastroenterol 22(4):1477–1486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Jouvenet N, Neil SJD, Zhadina M, Zang T, Kratovac Z, Lee Y, Mcnatt M, Hatziioannou T, Bieniasz PD (2009) Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 83:1837–1844

    Article  CAS  PubMed  Google Scholar 

  22. Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J (2009) Inhibition of Lassa and Marburg virus production by tetherin. J Virol 83:2382–2385

    Article  CAS  PubMed  Google Scholar 

  23. Pan XB, Han JC, Cong X, Wei L (2012) BST2/tetherin inhibits dengue virus release from human hepatoma cells. PLoS One 7(12):e51033

    Article  CAS  PubMed Central  Google Scholar 

  24. Giovannoni F, Damonte E, García C (2015) Cellular promyelocytic leukemia protein is an important dengue virus restriction factor. PLoS One 10(5):e0125690

    Article  PubMed  PubMed Central  Google Scholar 

  25. North AJ (2006) Seeing is believing? A beginners’ guide to practical pitfalls in image acquisition. J Cell Biol 172(1):9–18

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cybele C. García .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Giovannoni, F., Cárcamo, J.R.P., Morell, M.L., Cordo, S.M., García, C.C. (2018). Identifying Restriction Factors for Hemorrhagic Fever Viruses: Dengue and Junín. In: Salvato, M. (eds) Hemorrhagic Fever Viruses. Methods in Molecular Biology, vol 1604. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6981-4_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-6981-4_27

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-6980-7

  • Online ISBN: 978-1-4939-6981-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics